Vaxcyte
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -5,854 | 4,989 | -4,989 | |
EBITDA | -339,996 | -234,574 | -209,766 | -161,584 |
EBIT | -345,850 | -246,507 | -212,830 | -166,573 |
Net Income | -320,622 | -246,507 | -212,830 | -166,573 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -295,419 | -219,264 | -155,351 | -101,650 |
Cash | 260,843 | 173,959 | 281,080 | 306,744 |
Basic Shares | 139,506 | 136,089 | 136,196 | 136,033 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -15,845 | -75,000 | -9,196 | |
EBITDA | -741,768 | -448,082 | -392,095 | -214,030 |
EBIT | -766,628 | -463,927 | -402,266 | -223,483 |
Net Income | -766,628 | -463,927 | -402,266 | -223,485 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -669,290 | -475,054 | -364,667 | -176,438 |
Cash | 173,959 | 387,878 | 397,451 | 834,657 |
Basic Shares | 136,089 | 121,997 | 97,157 | 64,877 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$2.30 |
2025-12-31 | -$1.80 |
2025-09-30 | -$1.56 |
2025-06-30 | -$1.22 |